Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Lonza Expands its Manufacturing Capabilities at Tampa Site
Lonza announced the completion of the expansion of US$15 million multiphase solid oral dose development and manufacturing capabilities at its Tampa, FL USA site
Mapi Pharma to Build a New Sterile Injectable Production Plant in Jerusalem
Mapi Pharma has signed a long term lease agreement at the HarHotzvim HiTech Park in Jerusalem to establish a new sterile production plant for GA Depot injectable products
Colorcon Plans to Build a New Starch Manufacturing Unit
Colorcon announced its plans to build a new starch manufacturing unit in Amsterdam, Netherlands This new facility is planned to double the existing manufacturing capacity for Starch 1500, Pregelatinised Maize Starch, supporting the continued growth of Colorcons excipient business across the world
Kite Announces Plans to Build a New Manufacturing Industry
Kite announces plans to build industryleading cell therapy manufacturing capabilities with a new viral vector facility in Oceanside, California
Lonza Announces to Expand HPAPI Development and Manufacturing Capacity
Lonza announced an expansion of Highly Potent API HPAPI capabilities from development to commercial scale manufacturing, including formulation and delivery
Tergus Pharma to Build a New Commercial Manufacturing Facility with Great Point Partners
Tergus Pharma partners with Great Point Partners to build a new commercial manufacturing facility A 100,000 square feet new expansion will provide comprehensive services from development through manufacturing and will become a Contract Development and Manufacturing Organisation, or CDMO
Aldevron Breaks Ground to Build 14-Acre Gene Therapy Manufacturing Campus
Aldevron announces its plans to build 14acre gene therapy manufacturing campus at its headquarters in Fargo
Intertek Expands Pharmaceutical Services
Intertek announced an expansion of the pharmaceutical services for specialist inhalation and nasal product development for biologics in Melbourne, near Cambridge
WuXi Biologics Announced Construction of a 69 million Integrated Manufacturing Center in Southwest China
WuXi Biologics commenced construction of a new 69 million integrated manufacturing centre for innovative biologics at Chengdu, Southwest China
Thermo Fisher Invests US$ 50 million to Expand Bioproduction Capabilities
Thermo Fisher Scientific announced that it is investing US$50 million in its global bioproduction capabilities
